IL17A and cancer: This, in turn, restricts apoptosis via Bcl-2 and Bcl-xL and promotes cancer cell survival (Song et al. 2014), but IL-17C does not induce proliferation or epithelial–mesenchymal transition (EMT) as does IL-17A (see below).